New imaging agent could sharpen multiple myeloma detection
NCT ID NCT04561492
First seen Dec 16, 2025 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study is testing whether a new radioactive tracer called PentixaFor can find multiple myeloma lesions more accurately than the standard FDG tracer during PET scans. Researchers will compare the two tracers in 45 patients who are either starting first-line treatment or have relapsed. The goal is to improve initial staging and treatment evaluation for this blood cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP - Site Tenon
Paris, France
-
CHU Bordeaux
Bordeaux, France
-
Nantes UH
Nantes, France
Conditions
Explore the condition pages connected to this study.